CTRI/2023/01/048792Not yet recruiting未知
An Open Label, Single Centric Clinical Trial to assess the Clinical performanceof CRISPR-CAS based sensing platform using the BRCA1-Cas12-Strip Assay todetect Breast Cancer - CRISPR-CAS
Archeron Group0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1. Female patients aged 18 and above diagnosed with
- •Breast Cancer.
- •2. Able to provide blood sample (up to 10ml).
- •3. Patients ready to give written informed consent
- •and willing to comply with the study protocol.
Exclusion Criteria
- •1. Patients not eligible to give the required
- •blood sample in the opinion of the
- •investigator.
- •2. Pregnant or lactating females.
- •3. Presence of any severe medical or psychological
- •condition or chronic
- •condition/inflammation/infection that in the
- •opinion of the investigator would compromise
- •the patientâ??s safety or successful
- •participation in the study.
- •4. Patients undergoing chemotherapy.
Investigators
Similar Trials
Active, not recruiting
Phase 1
Clinical study of CV-HFG01 Tablets in management of Hyperuricemia and associated pain in gout.CTRI/2019/04/018495Climic Health Pvt Ltd
Active, not recruiting
Phase 1
Clinical study to assess the usefulness of CV-HFU01 tablets in management of recurrent UTI.CTRI/2019/04/018452Climic Health Pvt Ltd
Active, not recruiting
Phase 1
An Open Label, Prospective, Multi-Center Trial on the Effect of Anti-TNF Chimeric Monoclonal Antibody (Infliximab, Remicade) on Inflammatory and Fibrous Lesions in Patients with Intestinal Crohn's Diesease. ACTIF Trial. - Effect of Infliximab on MRI lesions in Crohn's - ACTIF studyCrohn's diseaseEUCTR2006-004784-58-GBniversity of Leuven Hospitals25
Completed
Not Applicable
Prospective, single-center, open clinical trial to compare two non-calibrated systems for the continuous measurement of cardiac output and stroke volume variation (LiDCO rapid®, ICON®) with a calibrated system using Thermodilutionin (PiCCO®) in adult cardiac surgical patients.Diseases that make a determination of cardiac output and stroke volume variation necessaryI97Postprocedural disorders of circulatory system, not elsewhere classifiedDRKS00005582Klinik für Anästhesiologie, operative Intensivmedizin und SchmerztherapieHelios Klinikum Krefeld50
Completed
Not Applicable
The effect of Rhodiola rosea Extract WS 1375 on attention and mental resource allocatioISRCTN29449049Dr. Willmar Schwabe GmbH & Co. KG (Germany)50